Innate Pharma (IPHA) Earnings
|
Expand Research on IPHA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | N/A | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | N/A | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/26/26  |
Q425 | N/A | -EUR0.14 | N/A | N/A | EUR2.55M | N/A | N/A | N/A | ||
| 11/13/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/17/25 |
Q225 | N/A | N/A | N/A | N/A | EUR10.3M | N/A | N/A | N/A | ||
| 5/13/25 |
Q125 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/27/25 |
Q424 | N/A | -EUR0.40 | N/A | N/A | EUR19.22M | N/A | N/A | N/A | ||
| 11/13/24 |
Q324 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 9/12/24 | Q224 | N/A | -EUR0.38 | N/A | N/A | EUR7.74M | N/A | N/A | N/A | ||
| 5/14/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
